| Michael Allen Foster, PT | |
|
700 Lilly Rd Ne, Olympia, WA 98506-5115 | |
| (360) 923-7000 | |
| (360) 923-7089 |
| Full Name | Michael Allen Foster |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 26 Years |
| Location | 700 Lilly Rd Ne, Olympia, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083263289 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT60281537 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of Washington | 9032022579 | 1480 |
News Archive
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
Going barefoot in parts of Africa, Asia and South America contributes to hookworm infections, which afflict an estimated 700 million of the world's poor. The parasitic worm lives in the soil and enters the body through the feet. By feeding on victims' blood, the worms cause anemia and, in children, stunted growth and learning problems.
Amid continued pressures to minimize errors and cut costs, hospitals are continuing to scramble to find solutions to problems plaguing health systems nationwide.
Bad news articles in the media increase women's sensitivity to stressful situations, but do not have a similar effect on men, according to a study undertaken by University of Montreal researchers at the Centre for Studies on Human Stress of Louis-H. Lafontaine Hospital.
There are about 77,000 people known to have cystic fibrosis. That's from the various cystic fibrosis registries available globally. The World Health Organization suggests that this number may be low, because there's no reporting on cystic fibrosis from the developing world. The accepted number, at the moment, is about 80,000. That's the one that is used for most of the work that's being done on cystic fibrosis.
› Verified 5 days ago
| Provider Name | Kaiser Foundation Health Plan Of Washington |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
Going barefoot in parts of Africa, Asia and South America contributes to hookworm infections, which afflict an estimated 700 million of the world's poor. The parasitic worm lives in the soil and enters the body through the feet. By feeding on victims' blood, the worms cause anemia and, in children, stunted growth and learning problems.
Amid continued pressures to minimize errors and cut costs, hospitals are continuing to scramble to find solutions to problems plaguing health systems nationwide.
Bad news articles in the media increase women's sensitivity to stressful situations, but do not have a similar effect on men, according to a study undertaken by University of Montreal researchers at the Centre for Studies on Human Stress of Louis-H. Lafontaine Hospital.
There are about 77,000 people known to have cystic fibrosis. That's from the various cystic fibrosis registries available globally. The World Health Organization suggests that this number may be low, because there's no reporting on cystic fibrosis from the developing world. The accepted number, at the moment, is about 80,000. That's the one that is used for most of the work that's being done on cystic fibrosis.
› Verified 5 days ago
| Provider Name | Penrose & Associates Physical Therapy Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1740480110 PECOS PAC ID: 1052403896 Enrollment ID: O20070823000833 |
News Archive
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
Going barefoot in parts of Africa, Asia and South America contributes to hookworm infections, which afflict an estimated 700 million of the world's poor. The parasitic worm lives in the soil and enters the body through the feet. By feeding on victims' blood, the worms cause anemia and, in children, stunted growth and learning problems.
Amid continued pressures to minimize errors and cut costs, hospitals are continuing to scramble to find solutions to problems plaguing health systems nationwide.
Bad news articles in the media increase women's sensitivity to stressful situations, but do not have a similar effect on men, according to a study undertaken by University of Montreal researchers at the Centre for Studies on Human Stress of Louis-H. Lafontaine Hospital.
There are about 77,000 people known to have cystic fibrosis. That's from the various cystic fibrosis registries available globally. The World Health Organization suggests that this number may be low, because there's no reporting on cystic fibrosis from the developing world. The accepted number, at the moment, is about 80,000. That's the one that is used for most of the work that's being done on cystic fibrosis.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Allen Foster, PT 700 Lilly Rd Ne, Olympia, WA 98506-5115 Ph: (360) 923-7000 | Michael Allen Foster, PT 700 Lilly Rd Ne, Olympia, WA 98506-5115 Ph: (360) 923-7000 |
News Archive
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
Going barefoot in parts of Africa, Asia and South America contributes to hookworm infections, which afflict an estimated 700 million of the world's poor. The parasitic worm lives in the soil and enters the body through the feet. By feeding on victims' blood, the worms cause anemia and, in children, stunted growth and learning problems.
Amid continued pressures to minimize errors and cut costs, hospitals are continuing to scramble to find solutions to problems plaguing health systems nationwide.
Bad news articles in the media increase women's sensitivity to stressful situations, but do not have a similar effect on men, according to a study undertaken by University of Montreal researchers at the Centre for Studies on Human Stress of Louis-H. Lafontaine Hospital.
There are about 77,000 people known to have cystic fibrosis. That's from the various cystic fibrosis registries available globally. The World Health Organization suggests that this number may be low, because there's no reporting on cystic fibrosis from the developing world. The accepted number, at the moment, is about 80,000. That's the one that is used for most of the work that's being done on cystic fibrosis.
› Verified 5 days ago
Ms. Claire Catherine Orazem, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 410 Providence Lane Ne, Olympia, WA 98506 Phone: 360-493-4995 Fax: 360-493-4470 | |
Mr. Jonathan P. Jove, MPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3000 Limited Ln Nw Ste 100, Olympia, WA 98502 Phone: 253-350-1869 Fax: 360-292-7247 | |
Laura Ashley Alyas, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3901 Capital Mall Dr Sw Ste D, Olympia, WA 98502 Phone: 360-709-6221 | |
Mrs. Cheryl Bonebrake Howard, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3015 Limited Ln Nw, Ste B, Olympia, WA 98502 Phone: 360-709-0700 Fax: 360-709-0703 | |
Angelica Kim, P.T., D.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 410 Providence Ln Ne, Emilie Gamelin Pavilion, 2nd Floor, Olympia, WA 98506 Phone: 360-493-4995 | |
Victoria Pfeifer, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 2102 Carriage St Sw Ste B, Olympia, WA 98502 Phone: 360-866-0408 | |
Rachael C Loebach, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 360 Lilly Rd Ne, Suite A, Olympia, WA 98506 Phone: 360-486-0640 Fax: 360-486-0641 |